This study aims to explore the imaging and electrophysiological characteristics of idiopathic inflammatory demyelinating diseases (IIDDs), and their correlation with clinical manifestations. It also evaluates the effectiveness of transcranial electrical stimulation in alleviating clinical symptoms of IIDDs patients, and analyzes the key factors affecting the treatment efficacy. By uncovering the overall and individual characteristics of IIDDs, this study seeks to enhance therapeutic outcomes through personalized neuromodulation programs. The findings will provide a basis for applying non-invasive brain stimulation (NIBS) in IIDDs treatment and offer new ideas for future personalized medicine approaches.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Expanded Disability Status Scale, EDSS score
Timeframe: At the 5-day point of treatment and 1 month following the end of treatment
Symbol Digit Modalities Test (SDMT) scale
Timeframe: At the 5-day point of treatment and 1 month following the end of treatment
Scoring results for tasks 1 and 7 in the Alzheimer disease assessment scale-cog(ADAS-cog)
Timeframe: At the 5-day point of treatment and 1 month following the end of treatment